Wide clinical and public engagement is crucial to ensure wide inclusiveness of clinical colleagues across NHSScotland. It is also vital to include the patients and the public as key stakeholders in this consultation to ensure the acceptability of the QPIs. We would like your comments on the Revised Clinical Trial Access QPI. In particular we would like to hear your views on:
o The appropriateness of the QPI that has been developed.
o The target level that has been set.
o Key points or areas that are not covered within the QPI
o Feasibility of measuring the QPI identified in a meaningful and comparative way (i.e. ‘like for like’ comparison)
A form to assist with submission of comments has been developed and should be used wherever possible. Please note that supporting evidence should be detailed along with comments where appropriate.